Plasma NfL is associated with mild cognitive decline in patients with diabetes
暂无分享,去创建一个
I. Shimomura | T. Matsuoka | K. Yoshiyama | N. Maeda | K. Yanagida | I. Mizuta | H. Adachi | J. Kozawa | M. Otsuki | Rikiya Maruyama | H. Iwahashi | Kohji Mori | S. Akamine | Noriko Marutani | D. Kanayama | S. Gotoh | Yukako Sakagami | Hiroshi Watanabe | N. Murayama | Manabu Ikeda | Takashi Kudo | Aki Nagase | Tesshin Miyamoto | Maki Hotta | Hiroyoshi Adachi
[1] Timothy J. Hohman,et al. Neurofilament relates to white matter microstructure in older adults , 2018, Neurobiology of Aging.
[2] C. Jack,et al. Plasma and CSF neurofilament light , 2019, Neurology.
[3] C. Enzinger,et al. Serum neurofilament light levels in normal aging and their association with morphologic brain changes , 2020, Nature Communications.
[4] K. Blennow,et al. Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype , 2007, European journal of neurology.
[5] P. Snyder,et al. Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis , 2016, Alzheimer's & dementia.
[6] Timothy J. Hohman,et al. Cerebrospinal fluid β-amyloid42 and neurofilament light relate to white matter hyperintensities , 2018, Neurobiology of Aging.
[7] G. Biessels,et al. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications , 2018, Nature Reviews Endocrinology.
[8] L. Fratiglioni,et al. Cognitive support at episodic encoding and retrieval: similar patterns of utilization in community-based samples of Alzheimer's disease and vascular dementia patients. , 1999, Journal of clinical and experimental neuropsychology.
[9] David T. Jones,et al. Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults , 2019, Neurology.
[10] Sterling C. Johnson,et al. Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.
[11] G. Piñol-Ripoll,et al. Ecological assessment of mild cognitive impairment and Alzheimer disease using the Rivermead Behavioural Memory Test. , 2014, Neurologia.
[12] D. Balota,et al. Neurofilament Light Predicts Decline in Attention but Not Episodic Memory in Preclinical Alzheimer's Disease. , 2020, Journal of Alzheimer's disease : JAD.
[13] D. Bennett,et al. Diabetes is related to cerebral infarction but not to AD pathology in older persons , 2006, Neurology.
[14] M. Yassuda,et al. Relations between attachment styles, ageism and quality of life in late life , 2010, International Psychogeriatrics.
[15] Y. Xiong,et al. An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer's disease. , 2017, Diabetes research and clinical practice.
[16] A. Bhansali,et al. Diabetes mellitus and risk of dementia: A meta‐analysis of prospective observational studies , 2013, Journal of diabetes investigation.
[17] L. Fratiglioni,et al. Similar patterns of cognitive deficits in the preclinical phases of vascular dementia and Alzheimer's disease , 2004, Journal of the International Neuropsychological Society.
[18] Nick C Fox,et al. Serum neurofilament light in familial Alzheimer disease A marker of early neurodegeneration , 2022 .
[19] L. Bäckman,et al. Cognitive Functioning in Alzheimer's Disease and Vascular Dementia: Further Evidence for Similar Patterns of Deficits , 2002, Journal of clinical and experimental neuropsychology.
[20] Philip S. Insel,et al. Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease , 2016, EMBO molecular medicine.
[21] V. Srikanth,et al. Type 2 diabetes mellitus and biomarkers of neurodegeneration , 2015, Neurology.
[22] A. Arauz,et al. Prospective Study of Single and Multiple Lacunar Infarcts Using Magnetic Resonance Imaging: Risk Factors, Recurrence, and Outcome in 175 Consecutive Cases , 2003, Stroke.
[23] K. Blennow,et al. Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease , 2018, Alzheimer's Research & Therapy.
[24] M. A. Viergever,et al. Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus , 2007, Diabetologia.
[25] Prashanthi Vemuri,et al. Age, vascular health, and Alzheimer disease biomarkers in an elderly sample , 2017, Annals of neurology.
[26] G. Capasso,et al. Mechanisms of cognitive dysfunction in CKD , 2020, Nature Reviews Nephrology.
[27] Brian A. Gordon,et al. Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease , 2018, Neurology.
[28] L. Grinberg,et al. Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration , 2014, Annals of neurology.
[29] K. Blennow,et al. CSF neurofilament light levels predict hippocampal atrophy in cognitively healthy older adults , 2017, Neurobiology of Aging.
[30] Alzheimer's Disease Neuroimaging Initiative. Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease , 2017 .
[31] M. Carnethon,et al. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. , 2020, The lancet. Diabetes & endocrinology.
[32] F. Schmitt,et al. Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology , 2016, Alzheimer's & Dementia.
[33] Shunichiro Shinagawa,et al. Comparison of the utility of everyday memory test and the Alzheimer's Disease Assessment Scale‐Cognitive part for evaluation of mild cognitive impairment and very mild Alzheimer's disease , 2013, Psychiatry and clinical neurosciences.
[34] E. Mori,et al. Everyday Memory Impairment of Patients with Mild Cognitive Impairment , 2005, Dementia and Geriatric Cognitive Disorders.
[35] H. Yao,et al. Hippocampal atrophy and memory dysfunction associated with physical inactivity in community‐dwelling elderly subjects: The Sefuri study , 2016, Brain and behavior.
[36] Ludwig Kappos,et al. Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases , 2013, PloS one.
[37] Nick C Fox,et al. Serum neurofilament light in familial Alzheimer disease , 2017, Neurology.
[38] Keith A. Johnson,et al. The impact of amyloid‐beta and tau on prospective cognitive decline in older individuals , 2018, Annals of neurology.
[39] Henrik Zetterberg,et al. Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression. , 2016, JAMA neurology.
[40] E. Wressle,et al. Validation of the Neurobehavioral Cognitive Status Examination and the Rivermead Behavioural Memory Test in investigations of dementia , 2012, Scandinavian journal of occupational therapy.
[41] Gabriel A. Devenyi,et al. Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer’s disease , 2020, Molecular Psychiatry.
[42] Á. Chamorro,et al. A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction , 2002, Neuroscience Letters.
[43] Vilmundur Gudnason,et al. Diabetes, markers of brain pathology and cognitive function , 2014, Annals of neurology.